US · Healthcare

Glorywin Entertainment Group Inc (GWIN)

Biotechnology

Glorywin Entertainment Group Inc (GWIN) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for GWIN

P/E ratio

18.00

Glorywin Entertainment Group Inc (GWIN) — FAQ

What is GWIN's P/E ratio?

The price-to-earnings (P/E) ratio for Glorywin Entertainment Group Inc (GWIN) is 18.00 (data as of 2026-03-24).

Does Glorywin Entertainment Group Inc pay a dividend?

Dividend yield is not available in the current snapshot for Glorywin Entertainment Group Inc (GWIN). Check the MyAverix Finance app for the latest dividend data.

What sector is Glorywin Entertainment Group Inc in?

Glorywin Entertainment Group Inc (GWIN) is classified in the Healthcare sector (Biotechnology industry).

What exchange is GWIN listed on?

GWIN is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)